Release Date: 26/11/09 16:13 Summary: Update on Progress of Significant Corporate Initiatives Price Sensitive: Yes Download Document 83.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%